News

Filter

Current filters:

Nephrology and Hepatology

26 to 35 of 96312 results

Avacta Life Sciences invests $16.2 million in Affimers as engineered alternative to antibodies

Avacta Life Sciences invests $16.2 million in Affimers as engineered alternative to antibodies

30-09-2014

Avacta Life Sciences, a division of Avacta Group is investing £10 million ($16.2 million) in the launch…

AvactaBiotechnologyResearchUK

UCB launches awareness campaign for non-motor symptoms of Parkinson's disease

UCB launches awareness campaign for non-motor symptoms of Parkinson's disease

30-09-2014

Belgian drugmaker UCB has launched an awareness-raising campaign around brain-related illnesses such…

EuropeNeurologicalPharmaceuticalSocial IssuesUCB

NeoGenomics appoints Robert Shovlin as chief operating officer

NeoGenomics appoints Robert Shovlin as chief operating officer

30-09-2014

Cancer-focused genetic testing service provider NeoGenomics has appointed Robert Shovlin as chief operating…

BiotechnologyBoardroomNeoGenomicsOncologyUSA

Intas launches DoceAqualip in India

30-09-2014

Indian drugmaker Intas Pharmaceuticals says it has successfully launched the world’s first DoceAqualip…

DoceAqualipdocetaxelIndiaIntas PharmaceuticalsMarkets & MarketingOncologyPharmaceutical

Innovative and orphan drugs to become more accessible in Russia

30-09-2014

The Russian Parliament (State Duma) plans to ease access to innovative and orphan drugs to the Russian…

PharmaceuticalRegulationResearchRussia

Biosimilars set to revolutionize global drug development industry

30-09-2014

Intellectual Property and Science business of Thomson Reuters today announced the release of Biosimilars:…

BiosimilarsBiotechnologyGlobalMarkets & MarketingResearch

Sanofi may build new plant in Russia

Sanofi may build new plant in Russia

30-09-2014

French pharma major Sanof plans to build a new plant in Russia, which is expected to be located in the…

AsiaPharmaceuticalProductionRussiaSanofi

Karolinska Development appoints Klaus Wilgenbus as interim chief executive

Karolinska Development appoints Klaus Wilgenbus as interim chief executive

30-09-2014

Swedish drug developer Karolinska Development has appointed current board member Klaus Wilgenbus as chief…

BiotechnologyBoardroomKarolinska DevelopmentKlaus WilgenbusSweden

Jay Feingold appointed CMO at ADC Therapeutics amid large-scale hiring drive

Jay Feingold appointed CMO at ADC Therapeutics amid large-scale hiring drive

30-09-2014

Oncology drug development company focused on antibody drug conjugates targeting major cancers, ADC Therapeutics,…

ADC TherapeuticsBoardroomOncologyPharmaceuticalSwitzerland

26 to 35 of 96312 results

Back to top